Race to Yes Calls on FDA Advisory Committee: Carefully Consider Data and Recommend Duchenne Drug Approval Based on Data and Direct Experience of Children and Clinicians
22 avr. 2016 12h49 HE
|
The Race to Yes
WASHINGTON, April 22, 2016 (GLOBE NEWSWIRE) -- In what is predicted to be the largest turnout in history at an FDA Advisory Committee meeting, more than 800 clinicians, researchers, patients and...